Kura Oncology (KURA) Other Non-Current Assets (2014 - 2026)

Kura Oncology (KURA) has 13 years of Other Non-Current Assets data on file, last reported at $14.0 million in Q1 2026.

• Other Non-Current Assets for Q1 2026 came in at $14.0 million, up 54.09% year-over-year; the trailing twelve-month figure through Mar 2026 was $14.0 million (up 54.09% YoY), and the FY2025 annual result was $14.5 million, up 85.38% from the prior year.
• Other Non-Current Assets eased to $14.0 million in Q1 2026 per KURA's latest filing, from $14.5 million in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $14.5 million in Q4 2025 and troughed at $210000.0 in Q1 2022.
• A 5-year average of $6.7 million and a median of $7.6 million in 2023 frame the typical range for Other Non-Current Assets.
• The sharpest annual moves came in 2022 and 2024: Other Non-Current Assets changed 0.0% in 2022, then soared 3550.48% in 2024.
• A 5-year view of Other Non-Current Assets shows it stood at $3.5 million in 2022, then surged by 117.32% to $7.6 million in 2023, then gained by 3.2% to $7.8 million in 2024, then jumped by 85.38% to $14.5 million in 2025, then declined by 3.8% to $14.0 million in 2026.
• Business Quant data shows KURA's Other Non-Current Assets at $14.0 million in Q1 2026, $14.5 million in Q4 2025, and $13.8 million in Q3 2025.